UHS appointed a new supported-self management team – comprising a CNS and a support worker to deliver a new aftercare pathway for prostate cancer, in partnership with the uro-oncology MDT. The pathway enabled men coming to the end of treatment to enter a self-managed pathway which incorporates remote PSA monitoring and timely re-access as required.
As part of the pathway it was important to ensure there was a clear selection criteria, monitoring schedule and recall criteria. There was a supported self management workshop developed for all men on the pathway
An IT platform allowed patients to access their PSA results within hours of the blood test being taken. The IT portal also enabled men to access education, self management, symptom control, and health and well being resources to support them in self managing their prostate cancer.
Men continue to have direct access to the clinical team via phone or email so clinical advice remains available within 24hrs (phone) or 48hrs (email).